The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy

European Urology

Volumn 61, Issue 2, 2012, Pages 245-253

  Chromecki, Thomas F ^a,b   Cha, Eugene K ^a   Fajkovic, Harun ^a,c   Margulis, Vitaly ^d   Novara, Giacomo ^e   Scherr, Douglas S ^a   Lotan, Yair ^d   Raman, Jay D ^f   Kassouf, Wassim ^g   Bensalah, Karim ^h   Weizer, Alon ⁱ   Kikuchi, Eiji ^j   Roscigno, Marco ^k   Remzi, Mesut ^l   Matsumoto, Kazumasa ^m   Walton, Thomas J ⁿ   Pycha, Armin ^o   Ficarra, Vincenzo ^e   Karakiewicz, Pierre I ^p   Zigeuner, Richard ^b   Pummer, Karl ^b   Shariat, Shahrokh F ^a   more..

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c General Hospital St Poelten   (Austria)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF PADOVA   (Italy)

^f PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^g MCGILL UNIVERSITY   (Canada)

^h PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^j KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k Ospedali Riuniti Bergamo   (Italy)

^l Landeskrankenhaus Weinviertel Korneuburg ^*  (Austria)

^m KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^o CENTRAL HOSPITAL OF BOLZANO   (Italy)

^p UNIVERSITÉ DE MONTRÉAL   (Canada)

more..

Author keywords

Cancer specific survival; Multifocal; Radical nephroureterectomy; Survival; Urinary tract cancer; Urothelial carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER MORTALITY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; KIDNEY PELVIS; LAPAROSCOPIC SURGERY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RADICAL NEPHROURETERECTOMY; TRANSITIONAL CELL CARCINOMA; TUMOR LOCALIZATION; UPPER TRACT UROTHELIAL CARCINOMA; URETER;

AGED; AGED, 80 AND OVER; CARCINOMA; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; URETER; URETERAL NEOPLASMS;

EID: 83955164247     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.09.017     Document Type: Article

References (25)

1. M. Rouprêt, R. Zigeuner, and J. Palou European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update Eur Urol 59 2011 584 594
2. H. Scher, R. Bahnson, and S. Cohen NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network Oncology (Williston Park) 12 1998 225 271
3. J.D. Raman, C.K. Ng, and D.S. Scherr Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy Eur Urol 57 2010 1072 1079
4. R.L. Favaretto, S.F. Shariat, and D.C. Chade The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center Eur Urol 58 2010 574 580
5. H. Isbarn, C. Jeldres, and S. Shariat Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma J Urol 182 2009 2177 2181
6. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, and A. Trotti American Joint Committee on Cancer (AJCC) Staging Manual ed. 7. 2010 Springer New York, NY
7. J. Epstein, M. Amin, V. Reuter, and F. Mostofi The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder Bladder Consensus Conference Committee. Am J Surg Pathol 22 1998 1435 1448
8. M. Remzi, A. Haitel, and V. Margulis Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients BJU Int 103 2009 307 311
9. E. Kikuchi, V. Margulis, and P. Karakiewicz Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma J Clin Oncol 27 2009 612 618
10. G. Novara, V. De Marco, and F. Gottardo Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers Cancer 110 2007 1715 1722
11. Fritsche H, Novara G, Burger M, et al. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma. Urol Oncol. In press. DOI: 10.1016/j.urolonc.2010.07.010.
12. G. Novara, K. Matsumoto, and W. Kassouf Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study Eur Urol 57 2010 1064 1071
13. S. Shariat, R. Favaretto, and A. Gupta Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma World J Urol 29 2011 481 486
14. T.F. Chromecki, B. Ehdaie, and G. Novara Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy World J Urol 29 2011 473 480
15. S. Shariat, G. Godoy, and Y. Lotan Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomy BJU Int 105 2010 1672 1677
16. C. Langner, G. Hutterer, T. Chromecki, S. Leibl, P. Rehak, and R. Zigeuner Tumor necrosis as prognostic indicator in transitional cell carcinoma of the upper urinary tract J Urol 176 2006 910 913 discussion 913-4
17. C. Seitz, A. Gupta, and S. Shariat Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study J Urol 184 2010 1895 1900
18. M. Roscigno, S. Shariat, and V. Margulis Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy J Urol 181 2009 2482 2489
19. M. Burger, S.F. Shariat, and H.M. Fritsche No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study World J Urol 29 2011 465 472
20. Vassilakopoulou M, de la Motte Rouge T, Colin P, et al. Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study. Cancer. In press. DOI: 10.1002/cncr.26172.
21. N. Hellenthal, S. Shariat, and V. Margulis Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration J Urol 182 2009 900 906
22. A. Ouzzane, P. Colin, and E. Xylinas Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy Eur Urol 60 2011 1258 1265
23. C.H. Kang, T.J. Yu, and H.H. Hsieh The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract Cancer 98 2003 1620 1626
24. Y. Matsui, N. Utsunomiya, and K. Ichioka Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract Urology 65 2005 279 283
25. B. Milojevic, M. Djokic, and S. Sipetic-Grujicic Bladder cancer after managing upper urinary tract transitional cell carcinoma: risk factors and survival Int Urol Nephrol 43 2011 729 735